EPISODE 017
Outset Medical CEO Leslie Trigg brings a career of success in medtech into a new approach to dialysis. Tablo, a sleek device, could enable dialysis companies an easier, cheaper way of providing dialysis to patients.
Podcast Guest
Leslie Trigg
President & CEO
Outset Medical
Before becoming Outset’s President and CEO, Leslie was the company’s Chief Operating Officer and also served as an Executive-in-Residence at Warburg Pincus. Prior to Outset, she was Executive Vice President at Lutonix. Before joining Lutonix, Leslie served as Chief Business Officer of AccessClosure. Earlier in her career, she was Vice President, Marketing for FoxHollow Technologies, helping to architect the strategy and commercial infrastructure that led to a successful IPO and subsequent acquisition by ev3/Covidien. Leslie’s management experience also includes senior leadership positions at Cytyc Corporation and breast cancer diagnostics company Pro-Duct Health, Inc., which was acquired by Cytyc. She began her medical device career at Guidant Corporation in new product global marketing.
In addition to her role at Outset, Leslie is also a board member of Cardiovascular Systems, Inc. (NASDAQ: CSII). She received her undergraduate degree from Northwestern University and her MBA from the Haas School of Business, UC Berkeley.
Meet Our Host
Geoff Pardo
Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.